Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN - Archive ouverte HAL Access content directly
Journal Articles Journal of the American Society of Nephrology Year : 2017

Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN

, (1) , (2) , (3) , (4) , , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , (13, 14)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Maria Chiara Marinozzi
  • Function : Author
Lubka Roumenina
Alexandre Hertig
Jérome Olagne
  • Function : Author
Tim Ulinski
  • Function : Author
Stéphane Burtey

Abstract

In C3 glomerulopathy (C3G), the alternative pathway of complement is frequently overactivated by autoantibodies that stabilize the C3 convertase C3bBb. Anti-C3b and anti-factor B (anti-FB) IgG have been reported in three patients with C3G. We screened a cohort of 141 patients with C3G and Ig-associated membranoproliferative GN (Ig-MPGN) for anti-FB and anti-C3b autoantibodies using ELISA. We identified seven patients with anti-FB IgG, three patients with anti-C3b IgG, and five patients with anti-FB and anti-C3b IgG. Of these 15 patients, ten were diagnosed with Ig-MPGN. Among those patients with available data, 92% had a nephrotic syndrome, 64% had AKI, and 67% had a documented infection. Patients negative for anti-C3b and anti-FB IgG had much lower rates of infection (17 [25%] patients with C3G and one [10%] patient with Ig-MPGN). After 48 months, four of 15 (26%) positive patients had developed ESRD or died. All 15 patients had high plasma Bb levels, six (40%) patients had low levels of C3, and nine (60%) patients had high levels of soluble C5b9. In vitro, IgG purified from patients with anti-FB Abs selectively enhanced C3 convertase activity; IgG from patients with anti-C3b/anti-FB Abs enhanced C3 and C5 cleavage. IgG from patients with anti-C3b Abs stabilized C3bBb and perturbed C3b binding to complement receptor 1 but did not perturb binding to factor H. In conclusion, the prevalence of anti-C3b/anti-FB Abs and alternative pathway activation is similar in Ig-MPGN and C3G, suggesting similar pathogenic mechanisms. Identification of the underlying defect in Ig-MPGN could lead to improved treatment.

Dates and versions

hal-01771617 , version 1 (19-04-2018)

Identifiers

Cite

Maria Chiara Marinozzi, Lubka Roumenina, Sophie Chauvet, Alexandre Hertig, Dominique Bertrand, et al.. Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN. Journal of the American Society of Nephrology, 2017, 28 (5), pp.1603 - 1613. ⟨10.1681/ASN.2016030343⟩. ⟨hal-01771617⟩
116 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More